The future of hospital pharmacyPharmacists must embrace change and communicate the essence of their profession in a high-tech world or risk being seen as dispensable. Clopidogrel's interactions with other drugs, genetics to be studied BREAST CANCER: Lapatinib helps control metastatic breast cancer Biologic agent added to aromatase inhibitor YOUR VOICE: Prescribing/diagnosing powers for pharmacists seen as dangerous Canadians' annual Rx spend = $578 Study indicates three out of four Canadians filling at least one prescription annually BREAST CANCER: Toremifene matches tamoxifen in early stage breast cancer outcomes New guide for palliative caregivers A revised source of information and a practical tool for helping people live through the suffering often experienced at end of life. Olmetec: new angiotensin II blocker coming soon Schering-Plough will soon be launching Olmetec and Olmetec Plus for the treatment of mild to moderate hypertension. B.C. drug substitution plan cost more than it saved: study Pantoprazole: preferred PPI in patients taking clopidogrel A new Canadian Medical Association Journal study suggests that the interaction between clopidogrel and proton pump inhibitors is clinically significant. First Previous 1253 1254 1255 1256 1257 Next Last
